Gadi Peleg

This profile gathers the share dealings of Gadi Peleg in Artemis Therapeutics, Inc. Between 11 March 2010 and 18 December 2018, the trades on record add up to 5 filings.

Market trades split into 3 purchases (€731k) and 1 sale (€42). Netting one side against the other leaves €731k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. In 2018 alone, the filings show no purchases and 1 sale.

The median purchase comes to €292k.

The newest entry dates from 19 December 2018: an open-market sale of €42, in Artemis Therapeutics, Inc. The last insider purchase was made public on 23 March 2010, 6,059 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 12 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.